Hydroxychloroquine-induced toxic myopathy causing respiratory failure

Chest

Volumn 131, Issue 2, 2007, Pages 588-590

  Siddiqui, Anita K ^a   Huberfeld, Seymour I ^a   Weidenheim, Karen M ^a   Einberg, Kenneth R ^a   Efferen, Linda S ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Chloroquine; Hydroxychloroquine; Myopathy; Respiratory failure

Indexed keywords

ANTIMALARIAL AGENT; CREATINE KINASE; ENALAPRIL; GLIBENCLAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE; STEROID;

AGED; ARTHRITIS; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CAUSE OF DEATH; DIABETES MELLITUS; DISEASE COURSE; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GERIATRIC PATIENT; HUMAN; HYPERTENSION; LUNG FUNCTION; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NON INVASIVE PROCEDURE; OBSTRUCTIVE AIRWAY DISEASE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 33847109862     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-1146     Document Type: Article

References (5)

1. Van Beek MJ, Piette WW. Antimalarials. Dermatol Clin 2001; 19:147-160
2. Estes ML, Ewing-Wilson D, Chou SM, et al. Chloroquine neuromyotoxicity: clinical and pathological perspective. Am J Med 1987; 82:447-455
3. Stein M, Bell MJ, Ang L-C. Hydroxychloroquine neuromyotoxicity. J Rheumatol 2000; 27:2927-2931
4. Sghirlanzoni A, Mantegazza R, Mora M, et al. Chloroquine myopathy and myasthenia-like syndrome. Muscle Nerve 1988; 11:114-119
5. Stauber WT, Hedge AM, Trout JT, et al. Inhibition of lysosomal function in red and white skeletal muscles by chloroquine. Exp Neurol 1981; 71:295-306